D.R. Horton has staged a sharp reversal this week — the stock up 5.3% to $151.16 — and the two most vocal bearish signals from last week have both moderated in tandem.
The clearest shift is in options. Put/call sentiment has unwound dramatically from its post-earnings extreme. The ratio now reads 0.86, well below its 20-day average of 0.97 and roughly half a standard deviation lighter than normal. That is a complete reversal from the 1.25-1.36 readings that dominated last week's coverage, when demand for downside protection was running three-plus standard deviations above the mean. Investors who rushed to hedge into and after the July 21 earnings release appear to have let those positions expire or roll off. The PCR has not been this relaxed since early July.
Short interest tells a more nuanced story, and this is where the picture diverges from a clean bull signal. SI has crept back to 4.1% of free float — broadly unchanged from the July 24 peak flagged in the previous note, and still up roughly 11% on the week. The fresh positioning that appeared after post-earnings covering ended has not reversed. At 12 million shares short and a days-to-cover of 5.69, new bears are sitting on losses after this week's rally but have not yet capitulated. The lending market gives them no pressure to hurry: availability remains extraordinarily loose at nearly 3,939% — meaning roughly 39 shares are available to borrow for every one currently lent out — and the cost to borrow has actually fallen 39% over the week to under 0.3%. There is no borrow squeeze forcing those positions to close.
The Street has shifted incrementally more constructive since the earnings print. Evercore ISI raised its target to $177 from $171 after the July 21 results, keeping an In-Line rating, while Keefe Bruyette trimmed its target to $167 from $175. RBC Capital, which maintains an Underperform, nudged its target marginally higher to $125. Taken together, the direction of travel is slightly positive but the consensus remains split: bulls at Goldman Sachs and UBS carry targets above $190, while RBC's $125 and Barclays' $141 bracket the bear case. The mean target of $164 implies roughly 8-9% upside from current levels. Valuation multiples have compressed over the past month — the P/E has pulled back 1.0 turn to 13.5x over 30 days — which the bulls frame as a re-entry opportunity and the bears read as a deteriorating growth story. Factor scores reflect that tension: EPS surprise ranks at the 70th percentile, suggesting a track record of beating, but the 30-day EPS momentum score of just 18 points to negative forward-estimate revisions in the near term.
The sector tailwind is real this week. Close peers PHM and LEN gained 8.4% and 7.1% respectively, both outperforming DHI's 5.3% weekly move, suggesting the rally is sector-driven rather than company-specific. TOL matched DHI almost exactly at 5.3%. The relative underperformance against the higher-beta names is consistent with DHI's larger scale and more defensive entry-level mix dampening upside capture in a risk-on week for the group.
With Q4 results not due until October 29, the next few weeks will test whether the short positions built after July's earnings hold their nerve at current prices or begin to cover — and whether the options market stays relaxed or finds a new catalyst to rebuild its defensive skew.
See the live data behind this article on ORTEX.
Open DHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
